We first observed that the DNAm score is associated with a difference in clinical presentation only among high-BEC or high-IgE patients, providing further evidence that our DNAm score reflects a spectrum of variation within the T2-high asthma endotype (Fig. 2c). Here, IGHE is linked to asthma.